# Tempero Bio jobs and careers

> 0 open roles at Tempero Bio as of October 23, 2026. Source: https://www.thejobsmap.com/company/tempero-bio

Tempero Bio is a clinical-stage biopharmaceutical company developing treatments for Substance Use Disorders and related disorders. Tempero Bio is a portfolio company of Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman. Our lead therapeutic drug candidate, TMP-301, is a potent, orally available, metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM) that is being investigated for the treatment of Substance Use Disorders, including Cocaine Use Disorder (CUD) and Alcohol Use Disorder (AUD). Additional discovery is also underway on the potential of TMP-301 to treat other addictive disorders, such as Methamphetamine Use Disorder (MUD) and Polysubstance Use Disorder (PUD).

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | United States |
| Employees | 1 to 10 |
| Website | https://temperobio.com |

## Leadership

- Paul Johnson, Chief Executive Officer

## Common questions

### Is Tempero Bio hiring right now?

Tempero Bio has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Tempero Bio's careers site.

### Where is Tempero Bio headquartered?

Tempero Bio is headquartered in United States.

### Who leads Tempero Bio?

Paul Johnson, Chief Executive Officer, is at the top of Tempero Bio's org chart.

### How do I apply for a job at Tempero Bio?

Pick a role on Tempero Bio's TheJobsMap page and select Apply. Every listing links to the original posting on Tempero Bio's own careers site, so you apply directly with the employer.